Level Four Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Level Four Advisory Services's EW Position: Q2 2026 in Review
Level Four Advisory Services increased its Edwards Lifesciences (EW) stake by 27% in Q2 2026, buying an estimated $84.9K and bringing the position to 4,742 shares worth $429K. The position accounts for 0.01% of the portfolio, ranked #656.
Level Four Advisory Services first reported a position in EW in Q4 2016 and has held it in 19 quarters since. The position peaked at $916K in Q2 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Level Four Advisory Services held 4,742 shares of Edwards Lifesciences worth $429K as of Q2 2026.
- Level Four Advisory Services bought 1,014 Edwards Lifesciences shares in Q2 2026, an estimated $84.9K.
- Edwards Lifesciences made up 0.01% of Level Four Advisory Services's portfolio in Q2 2026, its #656 holding.
- Level Four Advisory Services first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 19 quarters since.
- Level Four Advisory Services's Edwards Lifesciences position peaked at $916K in Q2 2024.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.